Nano-Ace

Beijing Nano-Ace Technology Co., Ltd. (hereinafter referred to as Nano-Ace Technology) was established in September 2010 with a registered capital of 67.9 million yuan and a 1000 square meter R & D and clean production workshop. It is a biotechnology company focusing on in vitro diagnostic reagents and instruments, and rapid food safety testing. Has a number of independent intellectual property rights. Nano-Ace Technology was recognized as a high-tech enterprise in Zhongguancun in March 2015, and was approved by the "Environmental Impact Report Form for the Production of Clinical Laboratory Analysis Instruments, In Vitro Diagnostic Reagents and Food Safety Testing Products Project Construction Project" in May 2017.

Nano-Ace Technology focuses on the research and development of products in the field of food safety testing and animal diseases, as well as in vitro diagnosis of infectious diseases, malignant tumors, and chronic diseases.

Based on the goal of "establishing a dominant brand position in the field of biotechnology and increasing the target market share", Nano-Ace Technology has focused on food safety testing, animal diseases, laboratory safety and other fields since 2016. Through the establishment of microfluidic chip technology, fluorescence immunochromatography, immunoaffinity column technology, enzyme-linked immunosorbent assay (ELISA), PCR technology and other platforms, the rapid detection of food safety and animal diseases with high automation, full quantification and multi-project joint inspection was realized. The products cover a number of detection indicators such as mycotoxins, veterinary drug residues, vitamins, animal diseases and heavy metals, and can be applied to milk and dairy products, grains, grain and oil, feed, aquatic products, animal husbandry and other industries.

Nano-Ace Technology has built a perfect fluorescent marker quantitative detection technology platform, products cover cardiovascular disease, bacterial infection inflammation diagnosis and other business areas. Provide professional products and services for rapid diagnosis and chronic disease management, pursue a friendly and convenient user experience, and strive to improve the quality of life and health.

Nano-Ace technology and nano center microfluidic technology experts jointly developed the nano cellulose modified microfluidic chip technology, and obtained 12 independent intellectual property rights. Nanocellulose modified microfluidic chip technology uses the unique properties and functions of nanocellulose nanosize, combined with the advantages of microfluidic high throughput, short reaction time, and small sample size, not only to achieve full automation, high sensitivity and high specificity of detection, but also to quickly realize the industrialization of IVD and food safety rapid detection reagents and instruments. As a new type of diagnostic technology, microfluidic chips will play an important role in the future diagnostic market. The new generation of diagnostic reagent products with completely independent intellectual property rights developed by us will be created in China and drive industrial upgrading.

Perfect detection system, humanized service concept, combined with the pace of continuous innovation, Nano-Ace technology starts from the "core" to protect human life and health.